Short-term treatment with transdermal nicotine affects the function of canine saphenous veins

W. Darrin Clouse, Kevin S. Rud, Richard D. Hurt, Virginia M Miller

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Experiments were designed to determine the effects of nicotine treatment on the functions of saphenous veins used for coronary artery bypass grafts in dogs. Dogs received either no treatment or transdermal nicotine for 5 weeks at doses of 11 mg, 22 mg or 44 mg/day. Saphenous veins were removed and suspended for the measurement of isometric force in organ chambers. Endothelium was removed mechanically from some rings. N(G)-mono- methyl-L-arginine (L-NMMA; 10-4 M) was used to inhibit the production of nitric oxide. Contractions to alpha2-adrenergic stimulation were decreased in veins from dogs treated with a 22- mg/day dose of transdermal nicotine. In addition, endothelium- dependent relaxations to adenosine-diphosphate (10-8-10-4 M) and the calcium ionophore A23, 187 (10-8-10-6 M) were decreased in veins from dogs with a 22-mg/day dose and increased in veins from dogs treated with a 44 mg/day dose. These relaxations were inhibited by L-NMMA. Plasma concentrations of oxidized products of nitric oxide were decreased only in dogs treated with 22 mg/day of nicotine. The relaxation of rings without endothelium (direct response on the smooth muscle) to nitric oxide were not altered by nicotine treatment. These results suggest that the short-term treatment of dogs with intermediate (22 mg/day) but not low (11 mg/day) or high (44 mg/day) doses of transdermal nicotine decreases the endothelial function of veins used for coronary artery bypass grafts. Therefore, changes in plasma products of nitric oxide and endothelium-dependent relaxations mediated by nitric oxide are related to the dose of nicotine treatment.

Original languageEnglish (US)
Pages (from-to)75-82
Number of pages8
JournalVascular Medicine
Volume5
Issue number2
StatePublished - 2000

Fingerprint

Saphenous Vein
Nicotine
Canidae
Dogs
Nitric Oxide
Endothelium
Veins
omega-N-Methylarginine
Coronary Artery Bypass
Transplants
Calcium Ionophores
Adrenergic Agents
Adenosine Diphosphate
Smooth Muscle
Arginine

Keywords

  • Adenosine diphosphate
  • Cotinine
  • Endothelium
  • Nitric oxide
  • Smooth muscle
  • Thrombin

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Short-term treatment with transdermal nicotine affects the function of canine saphenous veins. / Clouse, W. Darrin; Rud, Kevin S.; Hurt, Richard D.; Miller, Virginia M.

In: Vascular Medicine, Vol. 5, No. 2, 2000, p. 75-82.

Research output: Contribution to journalArticle

Clouse, W. Darrin ; Rud, Kevin S. ; Hurt, Richard D. ; Miller, Virginia M. / Short-term treatment with transdermal nicotine affects the function of canine saphenous veins. In: Vascular Medicine. 2000 ; Vol. 5, No. 2. pp. 75-82.
@article{b8568f7efd0948e9bba281be7f331f4a,
title = "Short-term treatment with transdermal nicotine affects the function of canine saphenous veins",
abstract = "Experiments were designed to determine the effects of nicotine treatment on the functions of saphenous veins used for coronary artery bypass grafts in dogs. Dogs received either no treatment or transdermal nicotine for 5 weeks at doses of 11 mg, 22 mg or 44 mg/day. Saphenous veins were removed and suspended for the measurement of isometric force in organ chambers. Endothelium was removed mechanically from some rings. N(G)-mono- methyl-L-arginine (L-NMMA; 10-4 M) was used to inhibit the production of nitric oxide. Contractions to alpha2-adrenergic stimulation were decreased in veins from dogs treated with a 22- mg/day dose of transdermal nicotine. In addition, endothelium- dependent relaxations to adenosine-diphosphate (10-8-10-4 M) and the calcium ionophore A23, 187 (10-8-10-6 M) were decreased in veins from dogs with a 22-mg/day dose and increased in veins from dogs treated with a 44 mg/day dose. These relaxations were inhibited by L-NMMA. Plasma concentrations of oxidized products of nitric oxide were decreased only in dogs treated with 22 mg/day of nicotine. The relaxation of rings without endothelium (direct response on the smooth muscle) to nitric oxide were not altered by nicotine treatment. These results suggest that the short-term treatment of dogs with intermediate (22 mg/day) but not low (11 mg/day) or high (44 mg/day) doses of transdermal nicotine decreases the endothelial function of veins used for coronary artery bypass grafts. Therefore, changes in plasma products of nitric oxide and endothelium-dependent relaxations mediated by nitric oxide are related to the dose of nicotine treatment.",
keywords = "Adenosine diphosphate, Cotinine, Endothelium, Nitric oxide, Smooth muscle, Thrombin",
author = "Clouse, {W. Darrin} and Rud, {Kevin S.} and Hurt, {Richard D.} and Miller, {Virginia M}",
year = "2000",
language = "English (US)",
volume = "5",
pages = "75--82",
journal = "Vascular Medicine (United Kingdom)",
issn = "1358-863X",
publisher = "SAGE Publications Ltd",
number = "2",

}

TY - JOUR

T1 - Short-term treatment with transdermal nicotine affects the function of canine saphenous veins

AU - Clouse, W. Darrin

AU - Rud, Kevin S.

AU - Hurt, Richard D.

AU - Miller, Virginia M

PY - 2000

Y1 - 2000

N2 - Experiments were designed to determine the effects of nicotine treatment on the functions of saphenous veins used for coronary artery bypass grafts in dogs. Dogs received either no treatment or transdermal nicotine for 5 weeks at doses of 11 mg, 22 mg or 44 mg/day. Saphenous veins were removed and suspended for the measurement of isometric force in organ chambers. Endothelium was removed mechanically from some rings. N(G)-mono- methyl-L-arginine (L-NMMA; 10-4 M) was used to inhibit the production of nitric oxide. Contractions to alpha2-adrenergic stimulation were decreased in veins from dogs treated with a 22- mg/day dose of transdermal nicotine. In addition, endothelium- dependent relaxations to adenosine-diphosphate (10-8-10-4 M) and the calcium ionophore A23, 187 (10-8-10-6 M) were decreased in veins from dogs with a 22-mg/day dose and increased in veins from dogs treated with a 44 mg/day dose. These relaxations were inhibited by L-NMMA. Plasma concentrations of oxidized products of nitric oxide were decreased only in dogs treated with 22 mg/day of nicotine. The relaxation of rings without endothelium (direct response on the smooth muscle) to nitric oxide were not altered by nicotine treatment. These results suggest that the short-term treatment of dogs with intermediate (22 mg/day) but not low (11 mg/day) or high (44 mg/day) doses of transdermal nicotine decreases the endothelial function of veins used for coronary artery bypass grafts. Therefore, changes in plasma products of nitric oxide and endothelium-dependent relaxations mediated by nitric oxide are related to the dose of nicotine treatment.

AB - Experiments were designed to determine the effects of nicotine treatment on the functions of saphenous veins used for coronary artery bypass grafts in dogs. Dogs received either no treatment or transdermal nicotine for 5 weeks at doses of 11 mg, 22 mg or 44 mg/day. Saphenous veins were removed and suspended for the measurement of isometric force in organ chambers. Endothelium was removed mechanically from some rings. N(G)-mono- methyl-L-arginine (L-NMMA; 10-4 M) was used to inhibit the production of nitric oxide. Contractions to alpha2-adrenergic stimulation were decreased in veins from dogs treated with a 22- mg/day dose of transdermal nicotine. In addition, endothelium- dependent relaxations to adenosine-diphosphate (10-8-10-4 M) and the calcium ionophore A23, 187 (10-8-10-6 M) were decreased in veins from dogs with a 22-mg/day dose and increased in veins from dogs treated with a 44 mg/day dose. These relaxations were inhibited by L-NMMA. Plasma concentrations of oxidized products of nitric oxide were decreased only in dogs treated with 22 mg/day of nicotine. The relaxation of rings without endothelium (direct response on the smooth muscle) to nitric oxide were not altered by nicotine treatment. These results suggest that the short-term treatment of dogs with intermediate (22 mg/day) but not low (11 mg/day) or high (44 mg/day) doses of transdermal nicotine decreases the endothelial function of veins used for coronary artery bypass grafts. Therefore, changes in plasma products of nitric oxide and endothelium-dependent relaxations mediated by nitric oxide are related to the dose of nicotine treatment.

KW - Adenosine diphosphate

KW - Cotinine

KW - Endothelium

KW - Nitric oxide

KW - Smooth muscle

KW - Thrombin

UR - http://www.scopus.com/inward/record.url?scp=0033912774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033912774&partnerID=8YFLogxK

M3 - Article

C2 - 10943583

AN - SCOPUS:0033912774

VL - 5

SP - 75

EP - 82

JO - Vascular Medicine (United Kingdom)

JF - Vascular Medicine (United Kingdom)

SN - 1358-863X

IS - 2

ER -